株探米国株
英語
エドガーで原本を確認する
false2024Q2000176169612-31Nasdaq0.006670.01667xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:CNYxbrli:sharesxbrli:purecrkn:segmentcrkn:slantWellcrkn:agreementcrkn:thirdPartyutr:sqft00017616962024-01-012024-06-3000017616962024-08-1300017616962024-06-3000017616962023-12-310001761696us-gaap:SeriesAPreferredStockMember2024-06-300001761696us-gaap:SeriesAPreferredStockMember2023-12-310001761696us-gaap:SeriesBPreferredStockMember2023-12-310001761696us-gaap:SeriesBPreferredStockMember2024-06-300001761696us-gaap:SeriesCPreferredStockMember2023-12-310001761696us-gaap:SeriesCPreferredStockMember2024-06-300001761696us-gaap:SeriesDPreferredStockMember2024-06-300001761696us-gaap:SeriesDPreferredStockMember2023-12-310001761696us-gaap:SeriesEPreferredStockMember2024-06-300001761696us-gaap:SeriesEPreferredStockMember2023-12-310001761696us-gaap:SeriesFPreferredStockMember2024-06-300001761696us-gaap:SeriesFPreferredStockMember2023-12-310001761696crkn:SeriesF1PreferredStockMember2024-06-300001761696crkn:SeriesF1PreferredStockMember2023-12-310001761696crkn:SeriesF2PreferredStockMember2023-12-310001761696crkn:SeriesF2PreferredStockMember2024-06-3000017616962024-04-012024-06-3000017616962023-04-012023-06-3000017616962023-01-012023-06-300001761696us-gaap:SeriesDPreferredStockMember2024-04-012024-06-300001761696us-gaap:SeriesDPreferredStockMember2023-04-012023-06-300001761696us-gaap:SeriesDPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesDPreferredStockMember2023-01-012023-06-300001761696us-gaap:SeriesAPreferredStockMember2024-04-012024-06-300001761696us-gaap:SeriesAPreferredStockMember2023-04-012023-06-300001761696us-gaap:SeriesAPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesAPreferredStockMember2023-01-012023-06-300001761696us-gaap:SeriesBPreferredStockMember2024-04-012024-06-300001761696us-gaap:SeriesBPreferredStockMember2023-04-012023-06-300001761696us-gaap:SeriesBPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesBPreferredStockMember2023-01-012023-06-300001761696us-gaap:SeriesCPreferredStockMember2024-04-012024-06-300001761696us-gaap:SeriesCPreferredStockMember2023-04-012023-06-300001761696us-gaap:SeriesCPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesCPreferredStockMember2023-01-012023-06-300001761696crkn:PreferredStockSeriesABAndCMember2024-04-012024-06-300001761696crkn:PreferredStockSeriesABAndCMember2023-04-012023-06-300001761696crkn:PreferredStockSeriesABAndCMember2024-01-012024-06-300001761696crkn:PreferredStockSeriesABAndCMember2023-01-012023-06-300001761696crkn:SeriesFF1AndF2PreferredStockMember2024-04-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMember2023-04-012023-06-300001761696crkn:SeriesFF1AndF2PreferredStockMember2024-01-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMember2023-01-012023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-12-310001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2023-12-310001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2023-12-310001761696us-gaap:CommonStockMember2023-12-310001761696us-gaap:CommonStockMemberus-gaap:CommonStockMember2023-12-310001761696us-gaap:AdditionalPaidInCapitalMember2023-12-310001761696us-gaap:RetainedEarningsMember2023-12-310001761696us-gaap:CommonStockMember2024-01-012024-03-310001761696us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-3100017616962024-01-012024-03-310001761696us-gaap:RetainedEarningsMember2024-01-012024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2024-03-310001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2024-03-310001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2024-03-310001761696us-gaap:CommonStockMember2024-03-310001761696us-gaap:CommonStockMemberus-gaap:CommonStockMember2024-03-310001761696us-gaap:AdditionalPaidInCapitalMember2024-03-310001761696us-gaap:RetainedEarningsMember2024-03-3100017616962024-03-310001761696us-gaap:CommonStockMember2024-04-012024-06-300001761696us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMemberus-gaap:SeriesAPreferredStockMember2024-04-012024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMemberus-gaap:SeriesBPreferredStockMember2024-04-012024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMemberus-gaap:SeriesCPreferredStockMember2024-04-012024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMemberus-gaap:SeriesFPreferredStockMember2024-04-012024-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMembercrkn:SeriesF1PreferredStockMember2024-04-012024-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2024-04-012024-06-300001761696us-gaap:CommonStockMembercrkn:SeriesF2PreferredStockMember2024-04-012024-06-300001761696us-gaap:RetainedEarningsMember2024-04-012024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2024-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2024-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2024-06-300001761696us-gaap:CommonStockMember2024-06-300001761696us-gaap:CommonStockMemberus-gaap:CommonStockMember2024-06-300001761696us-gaap:AdditionalPaidInCapitalMember2024-06-300001761696us-gaap:RetainedEarningsMember2024-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2022-12-310001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2022-12-310001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2022-12-310001761696us-gaap:CommonStockMember2022-12-310001761696us-gaap:AdditionalPaidInCapitalMember2022-12-310001761696us-gaap:RetainedEarningsMember2022-12-3100017616962022-12-310001761696us-gaap:CommonStockMember2023-01-012023-03-310001761696us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100017616962023-01-012023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2023-01-012023-03-310001761696us-gaap:RetainedEarningsMember2023-01-012023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-03-310001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2023-03-310001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2023-03-310001761696us-gaap:CommonStockMember2023-03-310001761696us-gaap:AdditionalPaidInCapitalMember2023-03-310001761696us-gaap:RetainedEarningsMember2023-03-3100017616962023-03-310001761696us-gaap:CommonStockMember2023-04-012023-06-300001761696us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2023-04-012023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-04-012023-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2023-04-012023-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2023-04-012023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2023-04-012023-06-300001761696us-gaap:RetainedEarningsMember2023-04-012023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesAPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesDPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesEPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF1PreferredStockMember2023-06-300001761696us-gaap:PreferredStockMembercrkn:SeriesF2PreferredStockMember2023-06-300001761696us-gaap:CommonStockMember2023-06-300001761696us-gaap:AdditionalPaidInCapitalMember2023-06-300001761696us-gaap:RetainedEarningsMember2023-06-3000017616962023-06-300001761696us-gaap:SeriesFPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesFPreferredStockMember2023-01-012023-06-300001761696crkn:SeriesF1PreferredStockConvertedToCommonStockMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredStockConvertedToCommonStockMember2023-01-012023-06-300001761696crkn:SeriesF2PreferredStockConvertedToCommonStockMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockConvertedToCommonStockMember2023-01-012023-06-300001761696crkn:SeriesF1F2AndF3PreferredStockMember2024-01-012024-06-300001761696crkn:SeriesF1F2AndF3PreferredStockMember2023-01-012023-06-300001761696us-gaap:RevolvingCreditFacilityMember2024-06-3000017616962024-06-252024-06-2500017616962023-08-112023-08-110001761696srt:MinimumMember2024-01-012024-06-300001761696srt:MaximumMember2024-01-012024-06-300001761696crkn:RetainageReceivableMember2024-06-300001761696crkn:RetainageReceivableMember2023-12-310001761696crkn:OneCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-06-300001761696crkn:TwoCustomerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-06-300001761696us-gaap:SeriesAPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesAPreferredStockMember2023-01-012023-06-300001761696us-gaap:SeriesBPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesBPreferredStockMember2023-01-012023-06-300001761696us-gaap:SeriesCPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesCPreferredStockMember2023-01-012023-06-300001761696crkn:ConvertibleNotesMember2024-01-012024-06-300001761696crkn:ConvertibleNotesMember2023-01-012023-06-300001761696us-gaap:SeriesFPreferredStockMember2024-01-012024-06-300001761696us-gaap:SeriesFPreferredStockMember2023-01-012023-06-300001761696crkn:SeriesF1PreferredStockMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredStockMember2023-01-012023-06-300001761696crkn:SeriesF2PreferredStockMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockMember2023-01-012023-06-300001761696crkn:WarrantsToPurchaseCommonStockexcludingPennyWarrantsMember2024-01-012024-06-300001761696crkn:WarrantsToPurchaseCommonStockexcludingPennyWarrantsMember2023-01-012023-06-300001761696crkn:WarrantsToPurchaseSeriesEPreferredStockMember2024-01-012024-06-300001761696crkn:WarrantsToPurchaseSeriesEPreferredStockMember2023-01-012023-06-300001761696crkn:OptionsToPurchaseCommonStockMember2024-01-012024-06-300001761696crkn:OptionsToPurchaseCommonStockMember2023-01-012023-06-300001761696crkn:UnvestedRestrictedStockUnitsMember2024-01-012024-06-300001761696crkn:UnvestedRestrictedStockUnitsMember2023-01-012023-06-300001761696crkn:CommitmentSharesMember2024-01-012024-06-300001761696crkn:CommitmentSharesMember2023-01-012023-06-300001761696crkn:VistaSerenaS.DeR.L.DeC.V.Member2024-06-3000017616962025-01-012024-06-300001761696us-gaap:NotesReceivableMember2024-03-300001761696crkn:SeniorSecuredPromissoryNoteMay2024Member2024-05-100001761696us-gaap:EquipmentMember2024-06-300001761696us-gaap:EquipmentMember2023-12-310001761696us-gaap:LeaseholdImprovementsMember2024-06-300001761696us-gaap:LeaseholdImprovementsMember2023-12-310001761696us-gaap:VehiclesMember2024-06-300001761696us-gaap:VehiclesMember2023-12-310001761696us-gaap:ComputerEquipmentMember2024-06-300001761696us-gaap:ComputerEquipmentMember2023-12-310001761696us-gaap:FurnitureAndFixturesMember2024-06-300001761696us-gaap:FurnitureAndFixturesMember2023-12-310001761696us-gaap:ConstructionInProgressMember2024-06-300001761696us-gaap:ConstructionInProgressMember2023-12-310001761696us-gaap:StandbyLettersOfCreditMember2024-06-300001761696us-gaap:StandbyLettersOfCreditMember2023-12-310001761696us-gaap:RevolvingCreditFacilityMember2023-12-310001761696us-gaap:LineOfCreditMember2024-06-300001761696us-gaap:LineOfCreditMember2023-12-310001761696crkn:CemenTechCapitalLLCMemberus-gaap:SecuredDebtMember2023-12-310001761696crkn:FordMotorCreditMemberus-gaap:SecuredDebtMember2023-03-310001761696crkn:MobilizationFundingIILLCMemberus-gaap:SecuredDebtMember2024-05-310001761696crkn:MobilizationFundingIILLCMember2024-04-012024-06-300001761696crkn:MobilizationFundingIILLCMember2024-05-310001761696crkn:MobilizationFundingIILLCMember2024-01-012024-06-300001761696us-gaap:CommonStockMemberus-gaap:CommonStockMember2024-01-012024-06-300001761696crkn:AtTheMarketOfferingMember2024-01-012024-06-300001761696crkn:AtTheMarketOfferingMembersrt:WeightedAverageMember2024-06-3000017616962023-07-202023-07-200001761696crkn:ELOCPurchaseAgreementMember2024-01-012024-06-300001761696crkn:ELOCPurchaseAgreementMember2023-07-202024-06-300001761696crkn:ELOCPurchaseAgreementMembersrt:WeightedAverageMember2024-06-3000017616962024-05-310001761696crkn:SeniorPreferredStockMember2024-06-300001761696us-gaap:CommonStockMemberus-gaap:SeriesFPreferredStockMember2024-05-310001761696us-gaap:SeriesFPreferredStockMembercrkn:StockIssuedThroughConversionMember2024-01-012024-06-300001761696us-gaap:SeriesFPreferredStockMembercrkn:CommonStockIssuedForDeemedDividendMember2024-01-012024-06-300001761696us-gaap:SeriesFPreferredStockMembercrkn:StockIssuedUponConversionMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredSharesMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredSharesMembercrkn:StockIssuedThroughConversionMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredSharesMembercrkn:CommonStockIssuedForDeemedDividendMember2024-01-012024-06-300001761696crkn:SeriesF1PreferredSharesMembercrkn:StockIssuedUponConversionMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockMembercrkn:StockIssuedThroughConversionMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockMembercrkn:CommonStockIssuedForDeemedDividendMember2024-01-012024-06-300001761696crkn:SeriesF2PreferredStockMembercrkn:StockIssuedUponConversionMember2024-01-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMembercrkn:StockIssuedThroughConversionMember2024-01-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMembercrkn:CommonStockIssuedForDeemedDividendMember2024-01-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMembercrkn:StockIssuedUponConversionMember2024-01-012024-06-300001761696crkn:SeriesFF1AndF2PreferredStockMember2024-05-012024-05-310001761696crkn:TwoThousandSixteenEquityIncentivePlanMember2019-06-130001761696crkn:TwoThousandSixteenEquityIncentivePlanMember2019-06-140001761696crkn:TwoThousandTwentyLongTermIncentivePlanMember2020-12-160001761696crkn:TwoThousandTwentyLongTermIncentivePlanMember2020-12-162020-12-160001761696crkn:TwoThousandTwentyTwoLongTermIncentivePlanMember2022-12-2200017616962023-01-012023-12-310001761696us-gaap:EmployeeStockOptionMember2024-01-012024-06-300001761696us-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300001761696us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-300001761696us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-06-300001761696us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-06-300001761696us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-04-012024-06-300001761696us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300001761696us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-06-300001761696us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-300001761696us-gaap:EmployeeStockOptionMember2024-06-300001761696us-gaap:RestrictedStockMember2023-12-310001761696us-gaap:RestrictedStockMember2024-01-012024-06-300001761696us-gaap:RestrictedStockMember2024-06-300001761696crkn:WarrantIssuedBetweenJune2020ToNovember2020Member2024-06-300001761696crkn:WarrantIssuedBetweenJune2020ToNovember2020Membersrt:MinimumMember2024-06-300001761696crkn:WarrantIssuedBetweenJune2020ToNovember2020Membersrt:MaximumMember2024-06-300001761696crkn:WarrantsIssuedBetweenJanuary2021ToDecember2021Member2024-06-300001761696crkn:WarrantsIssuedBetweenJanuary2021ToDecember2021Membersrt:MinimumMember2024-06-300001761696crkn:WarrantsIssuedBetweenJanuary2021ToDecember2021Membersrt:MaximumMember2024-06-300001761696crkn:WarrantsIssuedBetweenMarch2022ToOctober2022Member2024-06-300001761696crkn:WarrantsIssuedBetweenMarch2022ToOctober2022Membersrt:MinimumMember2024-06-300001761696crkn:WarrantsIssuedBetweenMarch2022ToOctober2022Membersrt:MaximumMember2024-06-300001761696crkn:WarrantsIssuedInJanuary2023Member2024-06-300001761696crkn:WarrantsIssuedInFebruary2023Member2024-06-300001761696crkn:WarrantsIssuedInFebruary2023Membersrt:MinimumMember2024-06-300001761696crkn:WarrantsIssuedInFebruary2023Membersrt:MaximumMember2024-06-300001761696crkn:WarrantsIssuedInJune2023Member2024-06-300001761696crkn:WarrantsIssuedInJune2023Membersrt:MinimumMember2024-06-300001761696crkn:WarrantsIssuedInJune2023Membersrt:MaximumMember2024-06-300001761696crkn:WarrantsIssuedInMarch2024Member2024-06-300001761696crkn:Hudson11601WilshireLLCMember2021-03-310001761696crkn:Hudson11601WilshireLLCMember2024-06-300001761696crkn:MobilizationNoteMember2024-05-012024-05-310001761696crkn:FilmSegmentMember2024-04-012024-06-300001761696crkn:FilmSegmentMember2023-04-012023-06-300001761696crkn:FilmSegmentMember2024-01-012024-06-300001761696crkn:FilmSegmentMember2023-01-012023-06-300001761696crkn:FiberOpticsSegmentMember2024-04-012024-06-300001761696crkn:FiberOpticsSegmentMember2023-04-012023-06-300001761696crkn:FiberOpticsSegmentMember2024-01-012024-06-300001761696crkn:FiberOpticsSegmentMember2023-01-012023-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FilmSegmentMember2024-04-012024-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FiberOpticsSegmentMember2024-04-012024-06-300001761696us-gaap:CorporateNonSegmentMember2024-04-012024-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FilmSegmentMember2023-04-012023-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FiberOpticsSegmentMember2023-04-012023-06-300001761696us-gaap:CorporateNonSegmentMember2023-04-012023-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FilmSegmentMember2024-01-012024-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FiberOpticsSegmentMember2024-01-012024-06-300001761696us-gaap:CorporateNonSegmentMember2024-01-012024-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FilmSegmentMember2023-01-012023-06-300001761696us-gaap:OperatingSegmentsMembercrkn:FiberOpticsSegmentMember2023-01-012023-06-300001761696us-gaap:CorporateNonSegmentMember2023-01-012023-06-300001761696crkn:FilmSegmentMember2024-06-300001761696crkn:FilmSegmentMember2023-06-300001761696crkn:FiberOpticsSegmentMember2024-06-300001761696crkn:FiberOpticsSegmentMember2023-06-300001761696us-gaap:SubsequentEventMember2024-07-012024-08-140001761696us-gaap:SubsequentEventMember2024-08-140001761696crkn:MobilizationNoteMemberus-gaap:SubsequentEventMember2024-07-012024-08-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
OR
o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number: 333-232426
Crown Electrokinetics Corp.
(Exact name of registrant as specified in its charter)
Delaware 47-5423944
(State or other jurisdiction of
 incorporation or organization)
(I.R.S. Employer
 Identification No.)
1110 NE Circle Blvd., Corvallis, Oregon 97330
(Address of principal executive offices) (Zip Code)
458.212.2500
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value
CRKN
The Nasdaq Capital Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o Accelerated filer o
Non-accelerated filer x Smaller reporting company x
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of common stock, $0.0001 par value per share, outstanding as of August 13, 2024 was 4,389,658.



CROWN ELECTROKINETICS CORP.
Page
i

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA
This Quarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements may be identified by such forward-looking terminology as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty. We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties.
All of our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”) could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Quarterly Report on Form 10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Quarterly Report on Form 10-Q that modify or impact any of the forward-looking statements contained in this Quarterly Report on Form 10-Q will be deemed to modify or supersede such statements in this Quarterly Report on Form 10-Q.
ii

PART I - FINANCIAL INFORMATION
Item 1. - Financial Statements.
CROWN ELECTROKINETICS CORP.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
June 30,
2024		 December 31,
2023
(Unaudited)
ASSETS
Current assets:
Cash $ 3,990  $ 1,059 
Prepaid and other current assets 378  728 
Accounts and retention receivable, net 3,351  83 
Note receivable 211  — 
Contract asset 1,244  — 
Total current assets 9,174  1,870 
Prepaid expenses - non-current 215  — 
Property and equipment, net 3,012  3,129 
Intangible assets, net 1,269  1,382 
Right-of-use assets 1,878  1,701 
Deferred debt issuance costs 292  1,306 
Other assets 160  139 
TOTAL ASSETS $ 16,000  $ 9,527 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 2,215  $ 1,500 
Accrued expenses 898  1,194 
Lease liabilities - current portion 735  655 
Notes payable - Current 636  429 
Contract liabilities 1,260  — 
Total current liabilities 5,744  3,778 
Notes payable - non-current 296  — 
Lease liabilities - non-current portion 1,178  1,072 
Total liabilities 7,218  4,850 
Commitments and Contingencies (Note 12)
STOCKHOLDERS’ EQUITY:
Preferred stock, par value $0.0001; 50,000,000 shares authorized, no shares outstanding
 —  — 
Series A preferred stock, par value $0.0001; 300 shares authorized, no shares outstanding as of June 30, 2024 and 251 shares outstanding as of December 31, 2023, respectively; liquidation preference zero as of June 30, 2024 and $261 as of December 31, 2023
 —  — 
Series B preferred stock, par value $0.0001; 1,500 shares authorized, no shares outstanding as of June 30, 2024 and 1,443 shares outstanding as of December 31, 2023; liquidation preference zero as of June 30, 2024 and $1,501 as of December 31, 2023
 —  — 
Series C preferred stock, par value $0.0001; 600,000 shares authorized, no shares outstanding as of June 30, 2024 and 500,756 shares outstanding as of December 31, 2023; liquidation preference zero as of June 30, 2024 and $531 as of December 31, 2023
 —  — 
Series D preferred stock, par value $0.0001; 7,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023; liquidation preference zero as of June 30, 2024 and December 31, 2023
 —  — 
Series E preferred stock, par value $0.0001; 77,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023.
 —  — 
Series F preferred stock, par value $0.0001; 9,073 shares authorized, no shares outstanding as of June 30, 2024 and 4,448 shares outstanding as of December 31, 2023; liquidation preference zero as of June 30, 2024 and $4,753 as of December 31, 2023.
 —  — 
Series F-1 preferred stock, par value $0.0001; 9,052 shares authorized, no shares outstanding as of June 30, 2024 and 653 shares outstanding as of December 31, 2023; liquidation preference zero as of June 30, 2024 and $696 as of December 31, 2023.
 —  — 
Series F-2 preferred stock, par value $0.0001; 9,052 shares authorized, no shares outstanding as of June 30, 2024 and 1,153 shares outstanding as of December 31, 2023; liquidation preference zero as of June 30, 2024 and $1,371 as of December 31, 2023.
 —  — 
Common stock, par value $0.0001; 800,000,000 shares authorized; 3,307,872 and 171,677 shares outstanding as of June 30, 2024 and December 31, 2023, respectively
 —  7 
Additional paid-in capital 135,418  121,665 
Accumulated deficit (126,636) (116,995)
Total stockholders’ equity 8,782  4,677 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 16,000  $ 9,527 
The accompanying notes are an integral part of these condensed consolidated financial statements.
1

CROWN ELECTROKINETICS CORP.
Condensed Consolidated Statements of Operations
(Unaudited)
(in thousands, except share and per share amounts)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2024 2023 2024 2023
Revenue $ 4,648  $ 37  $ 5,330  $ 59 
Cost of revenue, excluding depreciation and amortization (4,039) (23) (5,819) (54)
Depreciation and amortization (219) (81) (286) (263)
Research and development (1,111) (490) (1,867) (1,031)
General and administrative (4,187) (4,328) (5,970) (7,722)
Loss from operations (4,908) (4,885) (8,612) (9,011)
Other income (expense):
Interest expense (145) (2,508) (1,005) (4,525)
Loss on extinguishment of warrant liability —  —  —  (504)
Loss on extinguishment of debt —  (2,345) —  (2,345)
Gain on issuance of convertible notes —  —  —  64 
Change in fair value of warrants 23  2,130  —  7,736 
Change in fair value of notes —  (6,883) —  (7,000)
Other income (expense), net 1  (28) (24) (1,234)
Total other income (expense) (121) (9,634) (1,029) (7,808)
Loss before income taxes (5,029) (14,519) (9,641) (16,819)
Income tax expense —  —  —  — 
Net loss (5,029) (14,519) (9,641) (16,819)
Deemed dividend on Series D preferred stock —  —  —  (6)
Cumulative dividends on Series A preferred stock —  (5) —  (9)
Cumulative dividends on Series B preferred stock —  (29) —  (49)
Cumulative dividends on Series C preferred stock —  (10) —  (10)
Cumulative dividends on Series D preferred stock —  (53) —  (84)
Deemed dividend in connection with conversion of Series A, Series B, and Series C preferred stock (1,350) —  (1,350) — 
Deemed dividend in connection with conversion of Series F, F-1, and F-2 (3,874) —  (3,874) — 
Net loss attributable to common stockholders $ (10,253) $ (14,616) $ (14,865) $ (16,977)
Net loss per share attributable to common stockholders $ (5.89) $ (2,720.27) $ (14.98) $ (3,951.82)
Weighted average shares outstanding, basic and diluted: 1,739,995 5,373 992,278 4,296
The accompanying notes are an integral part of these condensed consolidated financial statements.
2

CROWN ELECTROKINETICS CORP.
Condensed Consolidated Statements of Stockholders’ Equity
(Unaudited)
(in thousands, except share and per share amounts)
Series A
 Preferred Stock		 Series B
 Preferred Stock		 Series C
 Preferred Stock		 Series D
 Preferred Stock		 Series E
 Preferred Stock		 Series F
 Preferred Stock		 Series F-1
 Preferred Stock		 Series F-2
 Preferred Stock		 Common Stock Additional
Paid-in
Capital 		Accumulated
Deficit 		Total
Stockholders’
Equity
Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount
Balance as of December 31, 2023 251 $ —  1,443 $ —  500,756 $ —  —  $ —  —  $ —  4,448 $ —  653 $ —  1,153 $ —  171,677  $ 7  $ 121,665  $ (116,995) $ 4,677 
Issuance of common stock in connection with equity line of credit —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  140,904 3  1,388  —  1,391 
Issuance of common stock/at-the-market offering, net of offering costs —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  32,163 —  588  —  588 
Stock-based compensation —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  274  —  274 
Net loss —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  (4,612) (4,612)
Balance at March 31, 2024 (unaudited) 251 $ —  1,443 $ —  500,756 $ —  —  $ —  —  $ —  4,448 $ —  653 $ —  1,153 $ —  344,744 $ 10  $ 123,915  $ (121,607) $ 2,318 
Issuance of common stock in connection with equity line of credit —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  1,599,123  —  9,343  —  9,343 
Issuance of common stock upon the conversion of Series A preferred stock (251) —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  36,220  —  —  —  — 
Issuance of common stock upon the conversion of Series B preferred stock —  —  (1,443) —  —  —  —  —  —  —  —  —  —  —  —  —  220,782  —  —  —  — 
Issuance of common stock upon the conversion of Series C preferred stock —  —  —  —  (500,756) —  —  —  —  —  —  —  —  —  —  —  78,056  —  —  —  — 
Issuance of common stock upon the conversion of Series F preferred stock —  —  —  —  —  —  —  —  —  —  (4,448) —  —  —  —  —  648,441  —  —  —  — 
Issuance of common stock upon the conversion of Series F-1 preferred stock —  —  —  —  —  —  —  —  —  —  —  —  (653) —  —  —  113,576  —  —  —  — 
Issuance of common stock upon the conversion of Series F-2 preferred stock —  —  —  —  —  —  —  —  —  —  —  —  —  —  (1,153) —  140,264  —  —  —  — 
Vesting of restricted stock units —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  126,666  —  —  —  — 
Reclassification of common stock to additional paid-in capital to reflect no change in par value in connection with reverse stock split —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  (10) 10  —  — 
Stock-based compensation —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  2,150  —  2,150 
Net loss —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  (5,029) (5,029)
Balance at June 30, 2024 (unaudited) —  $ —  —  $ —  —  $ —  —  $ —  —  $ —  —  $ —  —  $ —  —  $ —  3,307,872  $ —  $ 135,418  $ (126,636) $ 8,782 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3

CROWN ELECTROKINETICS CORP.
Condensed Consolidated Statements of Stockholders’ Equity (Continued)
(Unaudited)
(in thousands, except share and per share amounts)





Series A
 Preferred Stock		 Series B
 Preferred Stock		 Series C
 Preferred Stock		 Series D
 Preferred Stock		 Series E
 Preferred Stock		 Series F
 Preferred Stock		 Series F-1
 Preferred Stock		 Series F-2
 Preferred Stock		 Common Stock Additional
Paid-in
Capital 		Accumulated
Deficit 		Total
Stockholders’
Equity
Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount Number Amount
Balance as of December 31, 2022 251 $ —  1,443 $ —  500,756 $ —  1,058 $ —  —  $ —  —  $ —  —  $ —  —  $ —  2,257 $ 2  $ 88,533  $ (88,005) $ 530 
Exercise of common stock warrants —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  729 1  2,061  —  2,062 
Issuance of common stock in connection with conversion of notes —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  210 —  516  —  516 
Issuance of common stock/At-the-market offering, net of offering costs —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  1,412 1  2,106  —  2,107 
Issuance of Series E preferred stock in connection with LOC —  —  —  —  —  —  —  —  —  —  —  5,000 —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  4,350  —  4,350 
Deemed dividend for repricing of Series D preferred stock —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  6  (6) — 
Commitment to issue shares of common stock in connection with March waiver agreement —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  298  —  298 
Stock-based compensation —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  265 —  181  —  181 
Net loss —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  (2,300) (2,300)
Balance at March 31, 2023 (Unaudited) 251 $ —  1443 $ —  500,756 $ —  1,058 $ —  5,000 $ —  —  $ —  —  $ —  —  $ —  4,873 $ 4  $ 98,051  $ (90,311) $ 7,744 
Issuance of common stock in connection with Series A and Series B Dividends —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  50 —  —  —  — 
Issuance of common stock upon the conversion of Series E preferred stock —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  556 1  —  —  1 
Issuance of common stock in connection with conversion of October Notes —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  1,660 1  2,165  —  2,166 
Dividends paid in shares of Series D preferred stock —  —  —  —  —  —  —  —  —  139 —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Series D preferred stock exchanged for Series F preferred stock in connection with Exchange Agreements —  —  —  —  —  —  (1,197) —  —  —  1,847 —  —  —  —  —  —  —  (450) —  (450)
4

Conversion of Demand Notes and October Notes into Series F preferred stock in connection with Exchange Agreements —  —  —  —  —  —  —  —  —  —  3,198 —  3,583 —  —  —  —  —  1,276  —  1,276 
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements —  —  —  —  —  —  —  —  —  —  206 —  —  —  1,153 —  —  —  82  —  82 
Issuance of Series F-1 preferred stock —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  1,372  —  1,372 
Issuance of Series F-2 preferred stock —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  464  —  464 
Commitment to issue shares of common stock in connection with January Notes —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  2,410  —  2,410 
Commitment to issue shares of common stock in connection with LOC Notes —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  230  —  230 
Commitment to issue shares of Series E preferred stock in connection with LOC Notes —  —  —  —  —  —  —  —  (5,000) —  —  —  —  —  —  —  —  —  3,363  —  3,363 
Commitment to issue shares of common stock in connection with Demand Notes —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  286  —  286 
Stock-based compensation —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  132  —  132 
Net loss —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  (14,519) (14,519)
Balance as of June 30, 2023 (unaudited) 251 $ —  1,443 $ —  500,756 $ —  —  $ —  —  $ —  5,251 $ —  3,583 $ —  1,153 $ —  7,139 $ 6  $ 109,381  $ (104,830) $ 4,557 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

CROWN ELECTROKINETICS CORP.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)
Six months ended
June 30,
2024 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss (9,641) (16,819)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation 2,424  313 
Depreciation and amortization 286  372 
Loss on extinguishment of warrant liability —  504 
Change in fair value of warrant liability —  (7,736)
Loss on extinguishment of debt —  2,345 
Change in fair value of notes —  7,000 
Amortization of deferred debt issuance costs 1,014  4,049 
Amortization of right-of-use assets 383  1,045 
Amortization of notes payable (15) — 
Loss on disposal of equipment —  235 
Other expenses —  1,275 
Changes in operating assets and liabilities:    
Prepaid and other assets 114  (14)
Accounts receivable (3,268) — 
Contract asset (1,244) — 
Note receivables (211) — 
Contract liabilities 1,260  — 
Accounts payable 715  886 
Accrued expenses (296) (742)
Lease liabilities (374) (1,101)
Net cash used in operating activities (8,853) (8,388)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for acquisition of Amerigen 7 —  (644)
Purchase of equipment (56) (707)
Net cash used in investing activities (56) (1,351)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the exercise of warrants —  2,061 
Proceeds from the issuance of common stock / at-the-market offering, net of offering costs 588  2,107 
Proceeds from the issuance of notes in connection with line of credit —  2,350 
Proceeds from issuance of Series F-1 preferred stock —  2,328 
Proceeds from issuance of Series F-2 preferred stock —  748 
Proceeds from issuance of Senior Secured Notes, net of fees paid —  1,357 
Borrowing of notes payable 1,164  — 
Repayment of notes payable (646) (1,997)
Proceeds from the issuance of common stock in connection with equity line of credit, net of offering costs 10,734  — 
Net cash provided by financing activities 11,840  8,954 
     
Net increase / decrease in cash 2,931  (785)
Cash — beginning of period 1,059  821 
Cash — end of period $ 3,990  $ 36 
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest $ 90  $ 8 
Cash paid for taxes $ 2  $ — 
Right-of-use assets in exchange of operating lease liabilities $ 560  $ — 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of Series A preferred stock into common stock $ 251  $ — 
Conversion of Series B preferred stock into common stock $ 1,530  $ — 
Conversion of Series C preferred stock into common stock $ 501  $ — 
Conversion of Series F preferred stock into common stock $ 4,438  $ — 
Conversion of Series F-1 preferred stock into common stock $ 653  $ — 
Conversion of Series F-2 preferred stock into common stock $ 1,163  $ — 
Deemed dividend in connection with conversion of Series A, Series B, and Series C preferred stock $ 1,350  $ — 
Deemed dividend in connection with conversion of Series F-1, F-2, and F-3 preferred stock $ 3,874  $ — 
Net impact of reclassification of common stock to APIC in connection with reverse stock split $ 7  $ — 
Issuance of Series E preferred stock in connection with line of credit $ —  $ 9,943 
Issuance of Series F preferred stock in connection with exchange of Series D preferred stock $ —  $ 450 
Issuance of common stock in connection with conversion of notes $ —  $ 516 
Deemed dividend for repricing of series D preferred stock $ —  $ 6 
Commitment to issue shares of common stock in connection with Demand Notes $ —  $ 286 
Unpaid equipment included in accounts payable $ —  $ 92 
The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Notes to the Condensed Consolidated Financial Statements
(Unaudited)
Note 1 – Nature of Business and Liquidity
Organization
Crown Electrokinetics Corp. (the “Company”) was incorporated in the State of Delaware on April 20, 2015. Effective October 6, 2017, the Company’s name was changed to Crown Electrokinetics Corp. from 3D Nanocolor Corp. (“3D Nanocolor”).
The Company is commercializing technology for smart or dynamic glass. The Company’s electrokinetic glass technology is an advancement on microfluidic technology that was originally developed by HP Inc.
On December 20, 2022, the Company incorporated Crown Fiber Optics Corp., a Delaware based entity, to own and operate its acquired business from the acquisition of Amerigen 7, LLC (“Amerigen 7”) in January 2023. Crown Fiber Optics Corp. is accounted for as a wholly-owned subsidiary of Crown Electrokinetics, Corp.
Reverse Stock Split
On June 14, 2024, the Company’s board of directors authorized a reverse stock split (“June 2024 Reverse Stock Split”) at an exchange ratio of one-for-150 basis. The June 2024 Reverse Stock Split was effective on June 25, 2024, such that every 150 shares of common stock were automatically converted into one share of common stock. The Company did not issue fractional certificates for post-reverse split common stock shares in connection with the June 2024 Reverse Stock Split. Rather, all shares of common stock that were held by a common stockholder were aggregated and each common stockholder was entitled to receive the number of whole common stock shares resulting from the combination of the aggregated common stock shares. Any fractions resulting from the reverse split computation were rounded up to the next whole common stock share amount.
The number of authorized shares and the par value of the common stock was not adjusted. In connection with the June 2024 Reverse Stock Split, the conversion ratio for the Company’s outstanding convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion. All references to common stock and options to purchase common stock share data, per share data and related information contained in the condensed consolidated financial statements have been adjusted to reflect the effect of the June 2024 Reverse Stock Split.
On August 11, 2023, the Company’s board of directors authorized and effected a reverse stock split (“August 2023 Reverse Stock Split”) at an exchange ratio of one-for-60 basis.
Liquidity and Going Concern
The Company has incurred substantial operating losses and negative cash flows from operations since its inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the condensed consolidated financial statements, the Company had cash of approximately $4.0 million and an accumulated deficit of approximately $126.6 million as of June 30, 2024, a net loss of approximately $9.6 million for the six months ended June 30, 2024, and approximately $8.9 million of net cash used in operating activities for the six months ended June 30, 2024.
The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
The Company has obtained additional capital through the sale of debt or equity financings or other arrangements to fund operations including through its existing at-the-market offering, and $50.0 million equity line of credit; however, there can be no assurance that the Company will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing stockholders and newly issued shares may contain senior rights and preferences compared to currently outstanding shares of common stock. Issued debt securities may contain covenants and limit the Company’s ability to pay dividends or make other distributions to stockholders. If the Company is unable to obtain such additional financing, future operations would need to be scaled back or discontinued.
7

Due to the uncertainty in the Company’s ability to raise capital, management believes that there is substantial doubt in the Company’s ability to continue as a going concern for twelve months from the issuance of these condensed consolidated financial statements.
Note 2 – Basis of Presentation and Significant Accounting Policies
Basis of Presentation
The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions among consolidated entities were eliminated upon consolidation. The unaudited condensed consolidated financial statements were prepared in accordance with U.S. GAAP for financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X for interim financial reporting. As permitted under those rules, certain footnotes or other financial information can be condensed or omitted. These condensed consolidated financial statements and related disclosures have been prepared with the assumption that users of the interim financial information have read or have access to the audited consolidated financial statements for the preceding fiscal year. Accordingly, these statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024.
These condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal and recurring adjustments that are necessary for a fair statement of the Company’s consolidated financial information. The interim results of operations are not necessarily indicative of the results that may be expected for the full year, or for any other future annual or interim period.
Use of Estimates
The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenue and expenses during the reporting periods. Accounting estimates and assumptions are inherently uncertain. Management bases its estimates and assumptions on current facts, historical experience and various other factors believed to be reasonable under the circumstances. Actual results could differ materially and adversely from these estimates. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but not limited to, cost-to-cost (input) revenue recognition method, estimated fair value of warrant liability, stock option awards for stock-based compensation and operating lease right-of-use assets and liabilities.
Risks and Uncertainties
The Company is currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to the ongoing military conflict between Russia and Ukraine, as well as Israel and Hamas. The Company’s financial condition and results of operations may be materially adversely affected by any negative impact on the global economy and capital markets resulting from the conflict in Ukraine or any other geopolitical tensions.
The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Summary of Significant Accounting Policies
Reference is made to Note 3 Basis of Presentation and Significant Accounting Policies in our 2023 Form 10-K filed on April 1, 2024 for a detailed description of significant accounting policies. There have been no significant changes to our accounting policies as disclosed in our 2023 Form 10-K.
Revenue Recognition
The Company generates revenue primarily through construction and installation of fiber network infrastructure systems for its customers, and sales of smart glass products, which, together, represents two operating segments, the fiber optics group and film group. Revenues consistent of a combination of the following:
Fiber optics group services:
8

•Specialty Services performed for communications providers in connection with the deployment of underground fiber optic transmission lines.
•Specialty Services that involve the upfront procurement of specialized equipment that will be used to provide the services.
Film group products:
•Smart Window Inserts, which uses DynamicTint electrokinetic technology that allows windows to tint and transition from clear to true black.
The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements:
•Identification of the contract with the customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, the Company satisfies a performance obligation.
The Company has elected the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component when the time between the goods or service being transferred to the customer and the customer pays is one year or less.
Fiber optics group revenue recognition
The nature of the Company’s fiber optics group performance in its agreements is to customize output by constructing infrastructure that is customer specific. The Company is required to adhere to the rules and regulations that are outlined in an agreement between the Company and the Customer. As a result, the fiber optic contracts prevent the Company from directing the use of such output to any other entity except the specific customer. The customer is the only party that can benefit from the output that results from the Company’s performance of Specialty Services under the contract. As such, the Company’s performance does not create an asset with an alternative use and the Company has concluded that the Specialty Services are recognized over time.
To measure the progress of completion, the Company uses a cost-to-cost (input) method, by comparing costs incurred to date relative to the total expected costs to satisfy the performance obligation. The Company notes that when applying this method, it excludes the effects of any costs that do not depict its performance in transferring control of goods or services to the customer.
Film group revenue recognition
The Company’s film group has not entered into any material revenue contracts with its customers and no revenue is recognized for this operating segment for the three and six months ended June 30, 2024 and 2023.
Retainage
The Company’s customers have a contractual right to withhold payment of a retainage amount that typically ranges between 5% to 10% of the total contract consideration. The retainage can be utilized by customers for any claims that may arise after work is completed through one year after project completion. The retainage amount is expected to be collected upon the project's completion and acceptance by the customer. As of June 30, 2024 and December 31, 2023, the Company has recorded a retainage receivable of $0.3 million and zero, respectively, which is a component of the accounts receivable balance in the condensed consolidated balance sheet.

Accounts Receivable and Provision for Credit Losses
9

The provision for credit losses is based on the Company’s assessment of the collectability of its customer accounts. As of June 30, 2024, the Company had accounts receivable of $3.4 million, compared to $83,000 as of December 31, 2023.
The Company reviews the provision for credit losses by considering certain factors such as historical experience, industry data, credit quality, age of balances and current economic conditions that may affect a customer’s ability to pay. Uncollectible receivables are written off when all efforts to collect have been exhausted and recoveries are recognized when they are recovered. The Company’s provision for credit losses were zero as of June 30, 2024 and December 31, 2023.
Concentrations of risk and significant customers
Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable. The Company maintains its cash accounts with financial institutions where deposits, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) limits. The Company has not experienced any losses in such accounts through June 30, 2024.

The Company’s customers are generally large public or private companies with good credit and payment practices and a positive reputation in the industry at the time that the contracts are entered into. Furthermore, because it has the ability to stop transferring promised goods and services if payment is not received, the Company has concluded that collection risk is minimal.

One single customer accounted for 82% of accounts receivable as of June 30, 2024.

The Company’s revenue is primarily generated from its Fiber Optics segment. Two customers accounted for approximately 84% of the total revenue generated as of June 30, 2024.

As of June 30, 2024, the Company’s accounts payable primarily included costs associated with professional fees, subcontractor labor, equipment, and other supplies and materials.
Segment and Reporting Unit Information
Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s Chief Executive Officer is determined to be the CODM. The Company has two operating segments and two reportable segments as of June 30, 2024, which includes film group and fiber optics group. Revenue recognized during the three and six months ended June 30, 2024 relates to the fiber optics group.
Deferred Debt Issuance Costs
The Company accounts for debt issuance costs related to its line of credit and equity line of credit as a deferred asset on the condensed consolidated balance sheets, which is amortized over the life of the line of credit and equity line of credit. Since the Company has elected the fair value option for its convertible notes, upon a draw down, a portion of the deferred asset balance will be amortized and recognized as other income (expense) in the condensed consolidated statements of operations.
Warrants
The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the fair value of the instruments at each reporting period. The liability is subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the warrants issued by the Company was estimated using the Black-Scholes model.
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share attributable to common stockholders is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to common stockholders is computed using the sum of the weighted-average number of shares of common stock outstanding during the period and the effect of dilutive securities.
10

As the Company was in a net loss position for the three and six months ended June 30, 2024 and 2023, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders because the effects of potentially dilutive securities are antidilutive.
Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share as of June 30, 2024 and 2023 are as follows:
June 30,
2024 2023
Series A preferred stock —  3,146
Series B preferred stock —  — 
Series C preferred stock —  9,346
Convertible notes —  — 
Series F preferred stock —  501,579
Series F-1 preferred stock —  72,631
Series F-2 preferred stock —  124,946
Warrants to purchase common stock (excluding penny warrants) 16,523 11,801
Warrants to purchase Series E preferred stock 5,000 5,000
Options to purchase common stock 4,245 1,078
Unvested restricted stock units 231,206 52
Commitment shares 1,420 2,893
Total 258,394 732,472

Note 3 - Revenue

For the three months ended June 30, 2024, the Company generated revenue of $4.6 million, compared to $37,000 for the three months ended June 30, 2023. For the six months ended June 30, 2024, the Company's revenue was $5.3 million, compared to $0.1 million for the six months ended June 30, 2023. All revenues were derived from operations within the United States.

Contract balances

As of June 30, 2024, the Company's contract assets included unbilled receivables totaling $1.2 million, compared to zero as of December 31, 2023. There was no allowance for credit losses associated with contract assets as of June 30, 2024 and December 31, 2023. As of June 30, 2024, the contract liability balance was $1.3 million.
As of June 30, 2024, Crown Electrokinetics Corp. has recorded deferred revenue totaling $1.3 million. This amount represents the advance payments received under the Fixed Price Construction Agreement with Vista Serena, S. de R.L. de C.V., dated March 1, 2024. The contract stipulates the construction of two slant wells at Santa Maria Bay, with Crown Fiber Optics Corp. serving as the contractor. The Company did not record any deferred revenue as of December 31, 2023.

Remaining Performance Obligations

Remaining performance obligations represent non-cancellable contracted revenues that have not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenues in future periods.
The Company's remaining performance obligations for contracts were $6.0 million as of June 30, 2024, of which, the Company expects to recognize approximately 100% as revenue over the next twelve months and the remainder thereafter.


11

Note 4 – Balance Sheet Components
Prepaid and Other Current Assets
Prepaid and other current assets consisted of the following (in thousands):
June 30,
2024		 December 31,
2023
License fees $ 48  $ 158 
Professional fees 133  53 
General liability insurance 52  26 
Hudson warrant 53  86 
Prepaid rent
 62  277 
Other 30  128 
Total $ 378  $ 728 
Notes receivable
On March 30, 2024, the Company entered into a Senior Secured Promissory Note agreement (the “March Note”) with RamPro Construction and HDD, LLC, and Vero HDD, LLC (collectively, the "Borrowers"). Under this agreement, the Company holds a note receivable with a principal amount of $0.6 million. The note bears interest at a rate of 5% per annum, calculated on a 360-day year basis, with interest payable upon maturity. The principal and accrued interest are due on December 30, 2024.
On May 10, 2024, the Company and Borrowers executed a Senior Secured Promissory Note (the “May Note”). The May Note replaced the obligations from the Borrowers to Crown under the March Note and it was in substance an amendment of the March Note. The Company promised to lend $0.3 million to the Borrowers. The May Note bears interest at a rate of 5% per annum, calculated on a 360-day year basis, with interest payable upon maturity. The principal and accrued interest are due on May 25, 2025. As of June 30, 2024, the March Note was extinguished and there were no unamortized net fees or costs from the March Note.
The note is secured by all personal property and assets of the Borrowers and their subsidiaries, granting the Company a first priority security interest in these assets. In the event of default, the Company has the right to declare the unpaid balance immediately due and payable and pursue remedies available to a secured party under the Uniform Commercial Code. Events of default include non-payment of principal or interest, and the bankruptcy or insolvency of the Borrowers. The Company evaluates the collectability of the note receivable regularly and maintains an allowance for credit losses based on historical experience, current conditions, and reasonable forecasts. As of June 30, 2024, no allowance for credit losses had been deemed necessary for the May Note receivable.
12

Property and equipment, net
Property and equipment, net, consisted of the following (in thousands):
June 30,
2024		 December 31,
2023
Equipment $ 3,330  $ 3,155 
Leasehold improvements 362  362 
Vehicles 410  395 
Computers 55  56 
Furniture and Fixtures 3  3 
Construction-in-progress 87  77 
Total 4,247  4,048 
Less: accumulated depreciation (1,235) (919)
Property and equipment, net $ 3,012  $ 3,129 
Depreciation expense for the three months ended June 30, 2024 and 2023 was $0.1 million and $0.1 million, respectively. Depreciation expense for the six months ended June 30, 2024 and 2023 was $0.3 million and $0.3 million, respectively.
Intangible assets, net
Intangible assets, net, consists of the following (in thousands):
June 30,
2024		 December 31,
2023
Patents $ 1,800  $ 1,800 
Research license 375  375 
Customer relationships 4  4 
Total 2,179  2,179 
Less: accumulated amortization (910) (797)
Intangible assets, net $ 1,269  $ 1,382 
The following table represents the total estimated amortization of intangible assets for the five succeeding years and thereafter as of June 30, 2024 (in thousands):
Estimated
 Amortization
 Expense
Six months ended December 31, 2024 $ 122 
Year ended December 31, 2025 234 
Year ended December 31, 2026 197 
Year ended December 31, 2027 194 
Year ended December 31, 2028 195 
Thereafter 327 
Total $ 1,269 
For the three months ended June 30, 2024 and 2023, amortization expense was approximately zero and $0.1 million, respectively. For the six months ended June 30, 2024 and 2023, amortization expense was approximately $0.1 million and $0.1 million, respectively. As of June 30, 2024, the remaining weighted-average amortization period for acquired intangible assets was 0.70 years.
13


Accrued expenses
Accrued expenses consisted of the following (in thousands):
June 30,
2024		 December 31,
2023
Payroll and related expenses $ 118  $ 112 
Bonus -  1,000 
Taxes 56  51 
Other expenses 724  31 
Total $ 898  $ 1,194 

Note 5 – Deferred Debt Issuance Costs
Deferred debt issuance costs consist of the following (in thousands):
June 30,
2024		 December 31,
2023
Standing letter of credit $ 150  $ 150 
Equity letter of credit 554  554 
Line of credit $ 9,943  9,943 
Total 10,647  10,647 
Accumulated amortization (10,355) (9,341)
Deferred debt issuance costs $ 292  $ 1,306 
As of June 30, 2024, and December 31, 2023, the accumulated amortization was $10.4 million and $9.3 million, respectively. This represents an increase of $1.0 million, which is reflected in the cash flow statement for the six months ended June 30, 2024.
As of June 30, 2024, the deferred debt issuance costs related to the standing letter of credit and the line of credit has been fully amortized.

Note 6 – Notes Payable
Convertible Notes
In December 2023, the Company entered into a secured notes payable agreement with Cemen Tech Capital, LLC bearing an interest rate of 8.75% per year. In Q1 2023, the Company entered into a secured notes payable agreement with Ford Motor Credit bearing an interest rate of 6.96% per year. Both notes are secured by the vehicles financed. Monthly principal and interest payments are to be made commencing from the issuance date through January, 2030 and April, 2026 respectively.
In May 2024, the Company entered into a secured notes payable agreement for approximately $0.6 million with Mobilization Funding II, LLC (the “Mobilization Note”) bearing an interest rate of 3% per month. The note is collateralized by two construction agreements entered with two third parties, Glass Roots Construction, LLC and Fatbeam, LLC. Monthly principal and interest payments are to be made commencing from July 2024 through October 2024.

In May 2024, the Company entered into a Corporate Guaranty agreement (the “Guaranty”) with Mobilization Funding II, LLC (“Mobilization Note 2”). During the second quarter of 2024, the Company’s fiber optics group borrowed approximately $0.6 million under the Mobilization Note 2.
14

The Mobilization Note 2 bears interest at a rate of 57.0% per annum, calculated on a 360-day year basis, with interest payable upon maturity. The principal and accrued interest are due on October 31, 2024. As of June 30, 2024, the Company has fully repaid the Mobilization Note 2 and no further amounts were borrowable.

As of June 30, 2024, the expected future minimum principal payments under the Company’s notes payable is as follows (in thousands):
Expected Future Principal Note Payments
2024, remainder $ 636 
2025 33 
2026 60 
2027 60 
2028 65 
Thereafter 78 
Total 932 

As of June 30, 2024, the Company has repaid approximately $0.6 million of notes payable.

Note 7 - Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
• Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
• Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
• Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

As of June 30, 2024 and December 31, 2023, the Company’s aggregate fair value of warrants outstanding was nominal.
Note 8 – Stockholders’ Equity
At-the-Market Offering
As of June 30, 2024, the Company has received net proceeds on sales of 32,163 shares of common stock under the at-the-market offering of approximately $0.6 million after deducting $28,000 in commissions and expenses. The weighted-average price of the common stock was $19.11 per share.
Equity Line of Credit
On July 20, 2023 (“Closing Date”), the Company entered into the ELOC with a purchaser (“ELOC Purchaser”) whereby the Company has the right to sell up to an aggregate of $50.0 million of newly issued shares (the “ELOC Shares”) of the Company’s common stock. The aggregate number of shares that the Company can sell under the ELOC Purchase Agreement may not exceed 4.99% of the outstanding common stock, subject to certain exceptions set forth in the ELOC Purchase Agreement.
15

The purchase price of the shares of common stock that the Company elects to sell to the pursuant to the ELOC Purchase Agreement will be equal to 97.0% of the lower of (i) the lowest intraday sale price of the common stock on the Company’s current trading market on the applicable purchase date or (ii) the arithmetic average of the three lowest closing sale prices during the ten trading days immediately preceding the applicable purchase date. There is no upper limit on the price per share that ELOC Purchase could be obligated to pay for the common stock under the ELOC Purchase Agreement.
As of June 30, 2024, the Company received net proceeds on sales of 1,739,958 shares of common stock of approximately $10.7 million, after deducting commissions and expenses, at a weighted average price of $6.93 per share.
Preferred Stock Conversions
On May 2024, the Company executed a Second Amended and Restated Certificate of Designations, Preferences and Rights of its Series A, Series B, and Series C preferred stock (collectively “May 2024 COD”) following the approval of the Company’s Board of Directors and the requisite numbers of Series A, Series B, and Series C preferred stockholders (collectively “Senior Preferred Stocks”). Under the May 2024 COD, the Company revised the conversion price of its Senior Preferred Stocks to $0.0462 to incentivize the holders to convert their shares into the Company’s common stock. The following table summarizes the number of common stock issued upon the conversion of the Senior Preferred Stock:
Series of Preferred Stock Number of Preferred Stock Shares Converted Number of Common Stock Issued Upon Conversion
Series A 251 36,220
Series B 1,443 220,782
Series C 500,756 78,056
Total 502,450 335,058
The Company concluded that the conversion is an induced conversion and the fair value for the inducement is recognized as a deemed dividend. Due to the fact that the Company does not have any retained earnings, the Company will record the corresponding entries to additional paid-in capital and the debit/credit has a net nil impact on stockholders’ deficit during the period ended June 30, 2024. As of June 30, 2024, the Company recorded a $5,000 entry to additional paid-in capital and common stock par value related to the Senior Preferred Stock conversions.
On May 2024, the holders of Series F, F-1, and F-2 holders exercised their option to convert the shares into common stock utilizing the Alternate Conversion feature. As part of the original terms of the Series F, the shares may be converted to common stock based on the alternate conversion price that is lower than the original conversion price of $0.1478 per share (“Alternate Conversion”) if certain events were to occur (“Triggering Event”). The Triggering Events that occurred that enabled an Alternate Conversion is the (i) failure of the applicable registration statement to be filed with the SEC on or prior to the date that is five (5) days after the applicable filing deadline, and (ii) failure to pay dividends. The Alternate Conversion price is the lowest of (i) the conversion price in effect on the conversion date of the applicable Alternate Conversion, (ii) the greater of (x) the floor price of $0.1478, and (y) 80% of the volume-weighted average price (“VWAP”) of the common stock on the trading day preceding delivery day of the conversion notice, (iii) 80% of the VWAP of common stock as of the trading day of the conversion notice delivery day, and (iv) the greater of (x) the floor price of $0.1478, and (y) 80% of the price of the quotient (I) sum of three lowest days of common stock VWAP over 15 days, divided by (II) three. The following table summarizes the number of shares of common stock issued upon the conversion:
Series of Preferred Stock Number of Preferred Stock Shares Converted Number of Common Stock Issued through Conversion Number of Common Stock Issued for Deemed Dividend in Connection with Conversion Total Number of Common Stock Issued upon Conversion
Series F 4,448 648,441 38,799 648,441
Series F-1 653 113,576 — 113,576
Series F-2 1,153 140,264 10,990 140,264
Total 6,254 902,281 49,789 902,281
16

The Series F, F-1, and F-2 preferred stock were converted to common stock based on the triggering of the Alternative Conversions provisions. As such, the carrying value of the Series F, F-1, and F-2 preferred stock were derecognized. Additionally, the issued shares of common stock from the Series F conversion were recognized at par value and the triggered Alternative Conversion recognized as a deemed dividend. The Company will record the corresponding entries to additional paid-in capital and the debit/credit has a net nil impact on stockholders’ deficit during the period ended June 30, 2024. As of June 30, 2024, the Company recorded a $14,000 entry to additional paid-in capital and common stock par value related to the Series F, F-1, and F-2 conversions.
Note 9 – Stock-Based Compensation
Stock Options
The Company grants equity-based compensation under its 2020 Long-Term Incentive Plan (the “2020 Plan”) and its 2016 Equity Incentive Plan (the “2016 Plan”). The 2020 Plan and 2016 Plan allows the Company to grant incentive and nonqualified stock options, and shares of restricted stock to its employees, directors and consultants. On June 14, 2019, the Board of Directors of the Company approved increasing the number of shares allocated to the Company’s 2016 Equity Incentive Plan from 91,667 to 122,222.
On December 16, 2020, the Company adopted its 2020 Plan. Under the 2020 Plan, there are 88,889 shares of the Company’s common stock available for issuance and the 2020 Plan has a term of 10 years.
Under the 2016 Plan and the 2020 Plan, upon the exercise of stock options and issuance of fully vested restricted common stock, shares of common stock may be withheld to satisfy tax withholdings. The Company intends to net settle certain employee options to ensure adequate authorized shares under the Incentive Plan.
On December 22, 2022, the Company adopted its 2022 Long-Term Incentive Plan (the “2022 Plan”). Under the 2022 Plan, there are 70,000 shares of the Company’s common stock available for issuance and the 2022 Plan has a termination date of October 31, 2032.
A summary of activity under the Plans for the six months ended June 30, 2024 is as follows:
Shares
Underlying
Options 		Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual
Term
(Years)		 Aggregate
Intrinsic
Value
Outstanding at December 31, 2023 2,578 $ 9,868  8.1 $ — 
Granted 1,667 $ 14  9.9 — 
Forfeited —  $ —  —  — 
Outstanding at June 30, 2024 4,245 $ 5,998  8.4 $ — 
Exercisable at June 30, 2024 1,770 $ 14,245  6.8 $ — 
During the six months ended June 30, 2024, the Company recognized stock-based compensation of approximately $2.4 million related to stock options. The unrecognized compensation cost totaled approximately $0.1 million which is expected to be recognized over a weighted-average period of 1.0 year.
17

Stock-Based Compensation
The total stock-based compensation expense recognized was as follows (in thousands):
Three months ended
June 30,		 Six months ended
June 30,
2024 2023 2024 2023
Research and development expenses $ 22  $ 45  $ 52  $ 104 
Selling, general and administrative expenses 2,129  87  2,372  209 
Total stock-based compensation $ 2,151  $ 132  $ 2,424  $ 313 
As of June 30, 2024, the total unrecognized stock-based compensation cost related to outstanding unvested stock options that are expected to vest was $0.1 million, which the Company expects to recognize over an estimated weighted-average period of 1.0 years.
Restricted Stock Units
A summary of the Company’s restricted stock activity and related information is as follows:
Number of
Shares 		Weighted
Average
Grant-Date
Fair Value
Unvested at December 31, 2023 11,334 $ 37.74 
Granted 357,478 $ 9.10 
Vested (137,606) $ 6.35 
Unvested at June 30, 2024 231,206 $ 17.64 
During the six months ended June 30, 2024, the Company granted 357,478 restricted stock units and recognized stock-based compensation of approximately $2.1 million related to restricted stock units. The unrecognized compensation cost totaled approximately $0.9 million which is expected to be recognized over a weighted-average period of 0.7 years.
Note 10 – Warrants
The following table represents a summary of warrants to purchase shares of the Company’s common stock that are outstanding (in thousands, except for exercise price):
Warrant Issue Date Outstanding as of June 30, 2024 Exercise Price Expiration
June, 2020 - November, 2020 221
$10,044 - $41,850
 June, 2025 to November, 2025
January, 2021 - December, 2021 335
$3,510 - $50,625
 January, 2026 to December, 2026
March, 2022 - October, 2022 1,866
$2,880 - $18,000
 March, 2027 to October, 2027
January, 2023 282
$2,898
 January, 2028
February, 2023 1,372
$2,880 - $4,500
 February, 2028
June, 2023 7,446
$1,330 - $1,384
 June, 2028
March, 2024 5,001
$14
 March, 2029

18

See Note 7 – Fair value measurements with respect to valuation techniques and assumptions because the warrants are all liability-classified and subject to fair value measurement each reporting period.

Note 11 – Leases
Leases Under Crown Electrokinetics Film Division
The Company’s Crown Electrokinetics operating segment leases and subleases various office and laboratory spaces under non-cancelable operating leases with various expiration dates through fiscal 2027, certain of which contain renewal provisions. These renewal provisions are not reasonably certain to be exercised and therefore are not factored into the determination of lease payments. The Company’s Crown Electrokinetics Film operating segment have no lease agreements that are classified as finance leases.
In March 2021, the Company entered into a lease agreement with Hudson 11601 Wilshire, LLC, to lease 3,500 square feet of office space located in Los Angeles, California. The lease term is 39 months and expires on June 30, 2024. In April 2024, the Company entered into the first amendment for the Hudson lease to revise the payment schedule for the remaining lease term expiring on June 30, 2024. Subsequently, the Company entered into the second amendment in June 2024 to extend the lease term. The second amended lease expires in September 2027. The Company recorded a right-of-use asset of approximately $0.6 million and lease liabilities of approximately $0.6 million related to the first and second amended lease agreements

Leases Under Crown Fiber Optics Division

The Crown Fiber Optics operating segment of the Company leases various offices, storage spaces, and equipment under non-cancelable operating leases. These leases have expiration dates through fiscal 2026. Certain leases include renewal options; however, these renewal options are not considered reasonably certain to be exercised and are therefore excluded from the calculation of lease payments. The Crown Fiber Optics operating segment does not have any lease agreements classified as finance leases.
The components of lease expense are as follows (in thousands):
Three Months Ended
June 30,		 Six months Ended
June 30,
2024 2023 2024 2023
Operating leases:
Operating lease cost $ 165  $ 126  $ 384  $ 316 
Variable lease cost 20  (9) 20  49 
Operating lease expense $ 185  $ 117  $ 404  $ 365 

Supplemental cash flow information are as follows (in thousands):
Six months ended,
June 30
2024 2023
Operating cash flows - operating leases $ 378  $ 311 
Right-of-use assets obtained in exchange for operating lease liabilities $ 560  $ — 

19

Present value assumptions used in calculating the present value of lease payments for the operating leases were as follows:


June 30, 2024 December 31, 2023
Weighted-average remaining lease term - operating leases (in years) 1.9 1.7
Weighted-average discount rate - operating leases 12.0  % 12.0  %
As of June 30, 2024, future minimum payments are as follows (in thousands):
Operating
Leases
Six months ended December 31, 2024 $ 346 
Year ended December 31, 2025 775 
Year ended December 31, 2026 680 
Year ended December 31, 2027 409 
Total 2,210 
Less present value discount (297)
Operating lease liabilities $ 1,913 
Note 12 - Commitments and Contingencies
Litigation
From time to time, the Company is also involved in various other claims and legal actions that arise in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on its financial position, results of operations, liquidity or capital resources.
Future litigation may be necessary to defend ourselves and our partners by determining the scope, enforceability and validity of third party proprietary rights or to establish the Company’s proprietary rights. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors.
Loan Guaranty
In May 2024, the Company entered into a Corporate Guaranty agreement (the “Guaranty”) with Mobilization Funding II, LLC (“Mobilization”) and borrowed approximately $0.6 million as part of the Mobilization Note 2 discussed in Note 6. As part of the Guaranty, the Company agreed to be the primary obligor for the fiber optics group segment and be responsible for the repayment of all principal and interest borrowed under the Guaranty. As of June 30, 2024, all amounts under the Guaranty had been repaid and no further amounts were borrowable.
20

Note 13 – Segment Reporting

Crown Electrokinetics Corp. operates in two segments: the Electrokinetic Film Technology division and the Fiber Optics division.

Electrokinetic Film Technology Division: This division focuses on developing and selling optical switching films that can be embedded between sheets of glass or applied to the surface of glass or other rigid substrates like acrylic, to electronically control opacity. The technology, initially developed by Hewlett-Packard, enables a transition between clear and dark states in seconds. It is aimed at various applications including commercial buildings, automotive sunroofs, and residential windows. Crown partners with leading glass and film manufacturers for the mass production and distribution of its DynamicTint product. This segment also includes Smart Window Inserts, designed for retrofitting in commercial and residential settings, offering dynamic tinting along with additional insulation and soundproofing.

Fiber Optics Division: Crown’s involvement in fiber optics is relatively recent, marked by the acquisition of Amerigen 7 LLC’s assets, which was focused on the construction of 5G fiber optics infrastructure. Under the Crown Fiber Optics Corp. subsidiary, the company provides contracting services to the fiber optics and telecommunications infrastructure industry. Services range from program management and engineering to the construction of aerial and underground fiber networks. This division aims to capitalize on the demand for enhanced telecommunications bandwidth, with efforts to expand through selective market share increase, potential acquisitions, and leveraging new equipment like micro trenchers to gain a strategic advantage.

Our CODM does not evaluate operating segments using asset or liability information.

The following table presents a comparative summary of the Company’s revenues by reportable segment for the periods presented (in thousands):
For the three months ended,
June 30		 For the six months ended
June 30,
2024 2023 2024 2023
Segment Revenue
Film $ —  $ —  $ —  $ — 
Fiber Optics
 $ 4,648  $ 37  $ 5,330  59
Total Revenue $ 4,648  $ 37  $ 5,330  $ 59 

21


Operations by reportable segment for the three months ended June 30, 2024 and 2023, are as follows (in thousands):

For the three months ended June 30, 2024
Film Fiber Optics
Corporate and Other(a)
Total
Revenue $ —  $ 4,648  $ —  $ 4,648 
Cost of revenue, excluding depreciation and amortization —  (4,039) —  (4,039)
Depreciation and amortization (141) (78) —  (219)
Research and development (1,111) —  —  (1,111)
General and administrative —  (616) (3,571) (4,187)
Loss from operations (1,252) (85) (3,571) (4,908)
       
Other income (expense):      
Interest income (expense) —  (154) 9  (145)
Change in fair value of warrants —  —  23  23 
Other expense —  —  1  1 
Total other income (expense) —  (154) 33  (121)
       
Loss before income taxes $ (1,252) $ (239) $ (3,538) $ (5,029)
(a)The Corporate and Other are expenses that are not currently allocated between our film and fiber divisions.


For the three months ended June 30, 2023
Film Fiber Optics Corporate and Other(a) Total
Revenue $ —  $ 37  $ —  $ 37 
Cost of revenue, excluding depreciation and amortization —  (23) —  (23)
Depreciation and amortization (61) (20) —  (81)
Research and development (490) —  —  (490)
General and administrative —  (2,408) (1,920) (4,328)
Loss from operations (551) (2,414) (1,920) (4,885)
       
Other income (expense):      
Interest expense —  (3) (2,505) (2,508)
Loss on extinguishment of debt —  —  (2,345) (2,345)
Change in fair value of warrants —  —  2,130  2,130 
Change in fair value of notes —  —  (6,883) (6,883)
Other expense —  —  (28) (28)
Total other income (expense) —  (3) (9,631) (9,634)
       
Loss before income taxes $ (551) $ (2,417) $ (11,551) $ (14,519)
(a) The Corporate and Other are expenses that are not currently allocated between our film and fiber divisions.

22


For the six months ended June 30, 2024
Film Fiber Optics Corporate and Other(a) Total
Revenue $ —  $ 5,330  $ —  $ 5,330 
Cost of revenue, excluding depreciation and amortization —  (5,819) —  (5,819)
Depreciation and amortization (283) (3) —  (286)
Research and development (1,867) —  —  (1,867)
General and administrative —  (750) (5,220) (5,970)
Loss from operations (2,150) (1,242) (5,220) (8,612)
       
Other income (expense):      
Interest expense —  (163) (842) (1,005)
Other expense —  —  (24) (24)
Total other income (expense) —  (163) (866) (1,029)
       
Loss before income taxes $ (2,150) $ (1,405) $ (6,086) $ (9,641)

(a)The Corporate and Other are expenses that are not currently allocated between our film and fiber divisions.
For the six months ended June 30, 2023
Film Fiber Optics Corporate and Other(a) Total
Revenue $ —  $ 59  $ —  $ 59 
Cost of revenue, excluding depreciation and amortization —  (54) —  (54)
Depreciation and amortization (181) (82) —  (263)
Research and development (1,031) —  —  (1,031)
Selling, general and administrative (3,504) (2,936) (1,282) (7,722)
Loss from operations (4,716) (3,013) (1,282) (9,011)
       
Other income (expense):      
Interest expense —  (10) (4,515) (4,525)
Loss on extinguishment of warrant liability —  —  (504) (504)
Loss on extinguishment of debt —  —  (2,345) (2,345)
Gain on issuance of convertible notes —  —  64  64 
Change in fair value of warrants —  —  7,736  7,736 
Change in fair value of notes —  —  (7,000) (7,000)
Other expense —  —  (1,234) (1,234)
Total other income (expense) —  (10) (7,798) (7,808)
       
Loss before income taxes $ (4,716) $ (3,023) $ (9,080) $ (16,819)

(a)The Corporate and Other are expenses that are not currently allocated between our film and fiber divisions.


23

The following table presents long-lived assets by segment (in thousands):

For the six months ended,
June 30
2024 2023
Film Segment $ 3,418  $ 9,389 
Fiber Optics Segment $ 3,248  $ 1,933 
Other assets(a)
 $ 160  $ 33 
(a)“Other assets” primarily includes security deposits made with respect to the Company’s lease agreements.
24

Note 14 – Subsequent Events

From July 1, 2024 through August 14, 2024, the Company drew upon its equity line of credit (ELOC) agreement to issue and sell shares. The Company issued 535,000 shares of common stock at a weighted average price of $3.54 per share, resulting in net proceeds of approximately $1.9 million after commissions, fees, and offering costs.

Subsequent to June 30, 2024 and through the date of issuance of these interim condensed financial statements, the Company has repaid the full outstanding balance of $0.6 million and accrued interest for the Mobilization Note in July 2024.

25

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes thereto included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled “Risk Factors” included elsewhere in this report.
As an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012, we can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are electing to delay our adoption of such new or revised accounting standards. As a result of this election, our condensed consolidated financial statements may not be comparable to the condensed financial statements of other public companies.
Overview
We were incorporated in the State of Delaware on April 20, 2015. Effective October 6, 2017, our name was changed to Crown Electrokinetics Corp. from 3D Nanocolor Corp.
We commercialize technology for smart or dynamic glass. Our electrokinetic glass technology is an advancement on microfluidic technology that was originally developed by HP Inc.
Reverse Stock Split

On June 14, 2024, our board of directors authorized a reverse stock split (“June 2024 Reverse Stock Split”) at an exchange ratio of one-for-150 basis. The June 2024 Reverse Stock Split was effective on June 25, 2024, such that every 150 shares of common stock were automatically converted into one share of common stock. We did not issue fractional certificates for post-reverse split common stock shares in connection with the June 2024 Reverse Stock Split. All shares of common stock that were held by a common stockholder were aggregated and each common stockholder was entitled to receive the number of whole common stock shares resulting from the combination of the aggregated common stock shares. Any fractions resulting the reverse split computation were rounded up to the next whole common stock share amount.

The number of authorized shares and the par value of the common stock was not adjusted. In connection with the June 2024 Reverse Stock Split, the conversion ratio for our outstanding convertible preferred stock was proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion. All references to common stock and options to purchase common stock share data, per share data and related information contained in the condensed consolidated financial statements have been adjusted to reflect the effect of the June 2024 Reverse Stock Split.

In August 2023, our board of directors authorized and effected a reverse stock split (“August 2023 Reverse Stock Split”) at an exchange ratio of one-for-60 basis.
26


Results of Operations for the Three and Six Months Ended June 30, 2024 and 2023, respectively, (in thousands):

Three Months Ended
June 30, 		Six Months Ended
June 30,
2024 2023 Change 2024 2023 Change
Revenue $ 4,648  $ 37  $ 4,611  $ 5,330  $ 59  $ 5271 
Cost of revenue, excluding depreciation and amortization (4,039) (23) (4,016) (5,819) (54) (5,765)
Depreciation and amortization (219) (81) (138) (286) (263) (23)
Research and development (1,111) (490) (621) (1,867) (1,031) (836)
General and administrative (4,187) (4,328) 141  (5,970) (7,722) 1,752 
Loss from operations (4,908) (4,885) (23) (8,612) (9,011) 399 
   
   
Other income (expense)    
Interest expense (145) (2,508) 2,363  (1,005) (4,525) 3,520 
Loss on extinguishment of warrant liability -  -  -  -  (504) 504 
Loss on extinguishment of debt -  (2,345) 2,345  -  (2,345) 2,345 
Gain on issuance of convertible notes -  -  -  -  64  (64)
Change in fair value of warrants 23  2,130  (2,107) -  7,736  (7,736)
Change in fair value of notes -  (6,883) 6,883  -  (7,000) 7,000 
Other expense 1  (28) 29  (24) (1,234) 1,210 
Total other income (expense) (121) (9,634) 9,513  (1,029) (7,808) 6,779 
   
Loss before income taxes (5,029) (14,519) 9,490  (9,641) (16,819) 7,178 
Net loss $ (5,029) $ (14,519) 9,490  (9,641) (16,819) 7,178 
Revenue
Revenue is solely generated by Crown Fiber Optics, and was $4.6 million and $37,000 for the three months ended June 30, 2024 and 2023 and $5.3 million and $0.1 million for the six months ended June 30, 2024 and 2023, respectively. The increase in revenue of $4.6 million for the three months ended June 30, 2024 compared to the same period in 2023, is due to new contracts the Company entered into with new subcontractors in the first quarter of 2024.
The increase in revenue of $5.2 million for the six months ended June 30, 2024 compared to the same period in 2023, is due to new contracts the Company entered into with new subcontractors in the first quarter of 2024.
Cost of Revenue, excluding depreciation and amortization
Cost of revenue is solely generated by Crown Fiber Optics, and was $4.0 million and $23,000 for the three months ended June 30, 2024, and 2023 and $5.8 million and $0.1 million for the six months ended June 30, 2024 and 2023, respectively.
The increase in cost of revenue of $4.0 million for the three months ended June 30 2024 compared to the same period in 2023, is due to increases in compensation related to cost of sales of $0.3 million, subcontractor labor of $2.7 million, equipment cost of $0.6 million and other costs related to supplies, materials and maintenance of $0.4 million.
27

The increase in cost of revenue of $5.6 million for the six months ended June 30 2024 compared to the same period in 2023, is due to increases in compensation related to cost of sales of $0.9 million, insurance of $0.3 million, subcontractor labor of $3.0 million, equipment cost of $1.0 million and other costs related to supplies, materials and maintenance of $0.4 million.

Depreciation and Amortization

Depreciation and amortization expense for the three months ended June 30, 2024 and 2023, were $0.2 million and $0.1 million, respectively.

Depreciation and amortization expense for the six months ended June 30, 2024 and 2023, were $0.3 million and $0.3 milion, respectively.

Depreciation and amortization expense for the three and six months ended June 30, 2024 remained generally consistent with the same periods in 2023 due to comparable depreciation and amortization of the underlying property and equipment and intangible assets, respectively.

Research and Development

Research and development expenses were $1.1 million for the three months ended June 30, 2024 compared to $0.5 million for the three months ended June 20, 2023. The increase of $0.6 million is primarily related to an increase in salaries and benefits.

Research and development expenses were $1.9 million for the six months ended June 30, 2024 compared to $1.0 million for the six months ended June 20, 2023. The increase of $0.9 million is primarily related to an increase in salaries and benefits.

General and Administrative

General and administrative (“G&A”) expenses were $4.2 million and $4.3 million for the three months ended June 30, 2024 and 2023, respectively. The $0.1 million decrease in G&A expenses is primarily due to a decrease in professional fees of $1.2 million, decrease in insurance expense of $0.1 million, and decrease in other expenses of $0.4 million, partially offset by an increase in compensation and benefits related to wages of $1.3 million.

General and administrative (“G&A”) expenses were $6.0 million and $7.7 million for the six months ended June 30, 2024 and 2023, respectively. The $1.6 million decrease in G&A expenses is primarily due a decrease in professional fees of $1.6 million, decrease in insurance expense of $0.7 million, and decrease in other expenses of $0.2 million, partially offset by an increase in compensation and benefits related to wages of $0.5 million.

Interest expense

Interest expense was $0.1 million and $2.5 million for the three months ended June 30, 2024 and 2023, respectively. The decrease of $2.4 million is primarily related to a decrease in amortization of deferred asset related to the Company's standby letter of credit and equity line of credit.


Interest expense was $1.0 million and $4.5 million for the six months ended June 30, 2024 and 2023, respectively. The decrease of $3.5 million is primarily related to a decrease in amortization of deferred asset related to the Company's standby letter of credit and equity line of credit.

Loss on extinguishment of warrant liability

There was no loss on extinguishment of warrant liability for the three months ended June 30, 2024 and 2023, respectively.

Loss on extinguishment of warrant liability were zero and $0.5 million for the six months ended June 30, 2024 and 2023, respectively. Loss on extinguishment of warrant liability of $0.5 million related to a warrant inducement and exercise agreement with certain holders in connection with the 2022 Notes. There was no loss on extinguishment of warrant liability for the six months ended June 30, 2024.

Loss on extinguishment of debt

28

Loss on extinguishment of debt was zero and $2.3 million for the three months ended June 30, 2024 and 2023, respectively. The decrease is primarily related to repayments of all debt related to our standby letter of credit.

Loss on extinguishment of debt was zero and $2.3 million for the six months ended June 30, 2024 and 2023, respectively. The decrease is primarily related to repayments of all debt related to our standby letter of credit.


Gain on issuance of convertible notes

There was no gain on issuance of convertible notes for the three months ended June 30, 2024 and 2023.

Gain on issuance of convertible notes was zero and $0.1 million for the six months ended June 30, 2024 and 2023. The decrease is primarily related to repayments of all debt related to our standby letter of credit.


Change in fair value of warrants

Change in fair value of warrants were $23,000 and $2.1 million for the three months ended June 30, 2024 and 2023, respectively. The decrease is primarily due to change in fair value of warrants that were recorded in prior quarter and none for the current quarter.

Change in fair value of warrants were zero and $7.7 million for the six months ended June 30, 2024 and 2023, respectively. The decrease is primarily due to change in fair value of warrants that were recorded in prior quarter and none for the current quarter.

Change in fair value of notes

Change in fair value of notes were zero and $6.9 million for the three months ended June 30, 2024 and 2023, respectively. The $6.9 million recorded in prior quarter was primarily related to record of note issuances.

Change in fair value of notes were zero and $7.0 million for the six months ended June 30, 2024 and 2023, respectively. The $7.0 million recorded in prior quarter was primarily related to record of note issuances.

Other Income (Expense), Net

Other expense for the three months ended June 30, 2024 was nominal compared to $28,000 for the three months ended June 30, 2023. The decrease is due to a decrease in amortization expense reclass as well as other warrant issuances in connection with a waiver agreement.

Other expense for the six months ended June 30, 2024 was $23,000 compared to $1.2 million for the six months ended June 30, 2023. The decrease is due to a decrease in amortization expense reclass as well as other warrant issuances in connection with a waiver agreement.
Liquidity and Going Concern
June 30, 2024 June 30, 2023 Change
Cash at the beginning of the period $ 1,059  $ 821  $ 238 
Net cash used in operating activities (8,853) (8,388) (465)
Net cash used in investing activities (56) (1,351) 1,295 
Net cash provided by financing activities 11,840  8,954  2,886 
Cash at the end of the period $ 3,990  $ 36  $ 3,954 
We had an accumulated deficit of approximately $126.6 million, and a net loss of $9.6 million, and used approximately $8.9 million in net cash in operating activities for the six months ended June 30, 2024. We expect to continue to incur ongoing administrative and other expenses, including public company expenses.
29

In connection with our Equity Line of Credit (ELOC), the Company the Company received net proceeds on sales of     1,739,958 shares of common stock of approximately $10.7 million, after deducting commissions and expenses, at a weighted average price of $6.93 per share.
The following represents a summary of our 2023 activities:
•January 3, 2023: We secured net proceeds of $1.0 million from issuing senior secured notes with a principal of $1.2 million and debt discount of $0.2 million.
•February 2, 2023: We drew $2.0 million from the Line of Credit ("LOC"); issued an LOC Note, due in 60 days.
•April 4, 2023: We paid $0.3 million towards the LOC balance.
•May 16, 2023: We made a second draw of $0.2 million from the LOC; issued the 2nd LOC Note, due July 16, 2023, with 15% annual interest.
•May 26, 2023: We drew an additional $0.2 million from the LOC; issued the 3rd LOC Note, due June 2, 2023, with a $0.2 million commitment fee and no interest.
•June 13, 2023: We partially redeemed the LOC Note principal and fully redeemed the 2nd and 3rd LOC Notes, including accrued interest and fees, for approximately $2.1 million.
•July 25, 2023: We entered into a $0.1 million Demand Notes Agreement ("Q3 Demand Notes"), payable upon demand after our initial securities offering or by August 25, 2024.

We have obtained additional capital through the sale of debt or equity financings or other arrangements including through our existing ATM Offering, and the ELOC to fund operations; however, there can be no assurance that we will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing stockholders and newly issued shares may contain senior rights and preferences compared to currently outstanding shares of common stock. Issued debt securities may contain covenants and limit our ability to pay dividends or make other distributions to stockholders. If we are unable to obtain such additional financing, future operations would need to be scaled back or discontinued. Due to the uncertainty in our ability to raise capital, we believe that there is substantial doubt in our ability to continue as a going concern for twelve months from the issuance of these consolidated financial statements.
Cash Flows
Net Cash Used in Operating Activities
For the six months ended June 30, 2024, net cash used in operating activities was $8.9 million, which primarily consisted of our net loss of $9.6 million, adjusted for non-cash expenses of $3.5 million, which primarily consist of stock-based compensation of $2.4 million, depreciation and amortization of $0.4 million, amortization of deferred debt issuance costs of $1.0 million, and amortization of right of use assets of $0.4 million. The net change in operating assets and liabilities was $3.3 million, primarily consisting of an increase of deferred revenue of $1.3 million, prepaid and other assets of $0.1 million and accounts payable of $0.7 million, offset by a decrease of accounts receivable $3.3 million, contract asset of $1.2 million, note receivables of $0.2 million, accrued expenses of $0.5 million and lease liability of $0.4 million.
For the six months ended June 30, 2023, net cash used in operating activities was $8.4 million, which primarily consisted of our net loss of $16.8 million, adjusted for non-cash expenses of $9.5 million, which primarily consisted of a amortization of $5.1 million, loss on extinguishment of debt and warrant liabilities of $2.8 million, other expenses of $1.2 million primarily consisted of expenses incurred in stock issuance commitments, stock-based compensation of $0.3 million, depreciation and amortization of $0.4 million, offset by a 0.7 million gain related to the change in fair value of warrants and debt. The net change in operating assets and liabilities was $1.0 million.
Net Cash Used in Investing Activities
For the six months ended June 30, 2024, net cash used in investing activities was approximately $0.1 million, consisting of purchases of equipment.
For the six months ended June 30, 2023, net cash used in investing activities was approximately $1.4 million, consisting of cash paid for the acquisition of Amerigen 7 of approximately $0.6 million, and purchases of equipment totaling $0.7 million.
30

Net Cash Provided by Financing Activities
For the six months ended June 30, 2024, net cash provided by financing activities was $11.8 million, consisting of $10.7 million in proceeds from issuance of common stock in connection with equity line of credit, net of offering costs, borrowing of notes payable of $1.2 million, and proceeds from issuance of common stock of $0.6 million, partially offset by repayment of notes payable of $0.7 million.
For the six months ended June 30, 2023, net cash provided by financing activities was $8.9 million, consisting of net proceeds received from the issuance of common stock in connection with our ATM agreement totaling $2.2 million, proceeds from the exercise of common stock warrants of $2.1 million, net proceeds from the issuance of our 2023 Note (in connection with the Line of Credit) of $2.4 million proceeds from the issuance of senior secured notes of $0.9 million, proceeds from the issuance of our Demand Notes of $0.4 million, proceeds from the issuance of our Series F-1 preferred stock of $2.3 million, and proceeds from the issuance of our Series F-2 preferred stock of $0.8 million net of $0.1 million fees.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements during the periods presented, and we do not currently have any off-balance sheet arrangements, as defined in the SEC rules and regulations.
Critical Accounting Policies and Significant Judgments and Estimates
Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of our condensed consolidated financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates.
There are certain critical estimates that require significant judgment in the preparation of our consolidated financial statements. We consider an accounting estimate to be critical if:

•it requires us to make an assumption because information was not available at the time or it included matters that were highly uncertain at the time the estimate is made; and

•changes in the estimate or different estimates that could have been selected may have had a material impact on our financial condition or results of operations.

Our accounting estimates, specifically related to the impairment of long-lived assets, cost-to-cost (input) revenue recognition method and share-based compensation, play a crucial role in our financial reporting. Despite our thorough assessment, we have not identified any recent events or conditions necessitating revisions to our estimates and assumptions that would materially impact the carrying values of our assets or liabilities as of this Form 10-Q’s issuance date. These estimates may change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.

The use of the cost-to-cost (input) revenue recognition method requires us to make estimates regarding the total costs expected to complete each contract. These estimates are based on historical experience, project-specific factors, and other assumptions believed to be reasonable under the circumstances. The accuracy of these estimates can significantly impact the timing and amount of revenue recognized. Adjustments to estimated costs are made on a continuous basis and recognized in the period in which the revisions are identified. If the estimated total costs exceed the total contract revenue, a provision for the expected loss on the contract is recognized immediately.
Recent Accounting Pronouncements
See Note 2 to our condensed consolidated financial statements for a description of recent accounting pronouncements applicable to our financial statements.
JOBS Act Transition Period
As an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012, we can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
31

We are electing to delay our adoption of such new or revised accounting standards. As a result of this election, our condensed consolidated financial statements may not be comparable to the condensed financial statements of other public companies.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for a smaller reporting company.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, as of the end of the period covered by this report, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Act of 1934. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be included in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, relating to our company, including our consolidated subsidiaries.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management’s control objectives.

Our management, including our CEO and CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on this evaluation, our CEO and CFO concluded that the design and operation of our disclosure controls and procedures were not effective as of such date to provide assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to management as appropriate, to allow timely decisions regarding disclosures.

Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Rule 13a-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of the consolidated financial statements for external purposes in accordance with U.S. GAAP.
Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP and our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed, have inherent limitations, including the possibility of human error and the circumvention of overriding controls. Accordingly, even effective internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

32

Our management assessed the effectiveness of our internal control over financial reporting as of June 30, 2024. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework (2013). Management is committed to accurate and ethical business practices. Based on our evaluation, management concluded that our disclosure controls and procedures were not effective as of June 30, 2024, due to material weaknesses in our internal controls over financial reporting. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

Management noted the following deficiencies that we believe to be material weaknesses:

•Lack of documentation of processes and controls at the level appropriate for a public company;
•Inadequate design of information technology general and application controls over certain operating systems and system applications supporting financial reporting processes;
•Lack of segregation of duties in certain accounting and financial reporting processes; and
•Ineffective risk assessment controls, due to a lack of documentation of management’s periodic risk assessment.
Management’s view is that unethical, illegal, or inaccurate conduct in the operations and accounting for our company violates the trust and integrity of our company and is damaging to the interests of all stakeholders, and in the long-term misconduct injures the interests of even the individual whom it might initially benefit. This is reinforced periodically with informal conversations and is ingrained in the culture of our company. When questions arise, they are escalated to the CFO, CEO, or Board of Directors for review, investigation, direction, and consensus, and external opinion is sought if consensus is not achieved. The Senior Vice President of Accounting and CFO both have direct contact with all levels of review. Management intends to work internally and with third parties to ensure we have the proper controls in place going forward.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended June 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
33

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we are also involved in various other claims and legal actions that arise in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, we do not believe that the ultimate resolution of these actions will have a material adverse effect on our financial position, results of operations, liquidity or capital resources.
Future litigation may be necessary to defend ourselves and our partners by determining the scope, enforceability and validity of third party proprietary rights or to establish our proprietary rights. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
Item 1A. Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information required under this item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Other than those previously disclosed by the Company in its current reports on Form 8-K as filed with the SEC, there have been no unregistered sales of the Company’s equity securities during the period covered by this Quarterly Report.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
N/A
Item 5. Other Information
N/A
34

Item 6. Exhibits
3.1
3.2
3.3
3.4
4.1
4.2
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
31.1
31.2
32.1
32.2
35

101.INS Inline XBRL Instance Document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
36

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
Crown Electrokinetics Corp.
Dated: August 14, 2024
 /s/ Doug Croxall
Doug Croxall
Chief Executive Officer and
Principal Executive Officer
Dated: August 14, 2024
 /s/ Joel Krutz
Joel Krutz
Chief Financial Officer and
Principal Financial Officer
37
EX-31.1 2 crkn-20240630xex311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION
I, Doug Croxall, Chief Executive Officer of Crown Electrokinetics Corp. (the “registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended June 30, 2024;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 14, 2024
/s/ Doug Croxall
Doug Croxall
Chief Executive Officer
(Principal Executive Officer)

EX-31.2 3 crkn-20240630xex312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION
I, Joel Krutz, Chief Financial Officer of Crown Electrokinetics Corp. (the “registrant”), certify that:
1.I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended June 30, 2024;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 14, 2024
/s/ Joel Krutz
Joel Krutz
Chief Financial Officer
(Principal Financial Officer)

EX-32.1 4 crkn-20240630xex321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Each of the undersigned hereby certifies, in his or her capacity as an officer of Crown Electrokinetics Corp. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his/her knowledge:
(1)The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 14, 2024
/s/ Doug Croxall
Doug Croxall
Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 crkn-20240630xex322.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Each of the undersigned hereby certifies, in his or her capacity as an officer of Crown Electrokinetics Corp. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his/her knowledge:
(1)The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 14, 2024
/s/ Joel Krutz
Joel Krutz
Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.